HOME >> BIOLOGY >> NEWS
Wellcome Trust and GlaxoSmithKline announce partnership to target drug-resistant hospital infections

The Wellcome Trust and GlaxoSmithKline (GSK) today announced a collaboration to develop a new class of antibacterials to combat the rise of certain drug-resistant hospital-acquired infections, including those that lead to pneumonia. The collaboration is part of the Wellcome Trusts Seeding Drug Discovery initiative, aimed at tackling unmet medical needs.

GSK has received a 4 million award from the Trust to accelerate development of compounds for the treatment of Gram-negative bacteria which are becoming increasingly resistant to multiple antibacterials. GSK will make a matching contribution in staff, equipment, and other programme costs. The Trust will receive a financial consideration on any commercial product resulting from the collaboration.

"Our ability to tackle drug-resistant infections is reaching crisis level with few new antimicrobial agents on the horizon," says Dr Ted Bianco, Director of Technology Transfer at the Wellcome Trust. "Antibacterials are expensive to develop and may be held in reserve, limiting their market potential. It can be difficult, therefore, for companies to recoup their outlay in R&D costs.

This is where the Wellcome Trust believes it can make a difference through partnership. GSK has demonstrated a continuing commitment to discover and develop new antibacterials, aimed at addressing the growing threat of resistance. Our partnership will further support its research programmes."

The research will target Gram-negative bacteria, such as Pseudomonas, Klebsiella and Acinetobacter, which are increasingly resistant to available antibacterials and commonly cause hospital-acquired pneumonia and septic shock, particularly in patients in intensive care units. Without adequate therapy, patients often confront a poor prognosis mortality is high, and recovery, when it occurs, can be long and complicated.

Dr Patrick Vallance, Senior Vice President of Drug Discovery at GSK, commented: Infectio
'"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
29-Apr-2007


Page: 1 2

Related biology news :

1. Burroughs Wellcome Fund awards $14M to support physician-scientists
2. Burroughs Wellcome fund awards $8.25 million in grants to physician-scientists
3. Major Wellcome Trust award to take science from the bench to the bedside
4. A Wellcome brain gain for world leading neuroscience lab
5. Burroughs Wellcome Fund to support Project Suc-SEED at CIIT Centers for Health Research
6. BioMed Central applauds Wellcomes leadership on Open Access
7. Yale scientist studying virus infections named Burroughs Wellcome Investigator
8. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology
9. Trusting your instincts leads you to the right answer
10. Leeds Teaching Hospitals NHS Trust to host press conference call/webcast on data published in NEJM
11. GlaxoSmithKlines rotavirus vaccine candidate shown effective

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... March 05, 2020 , ... ... research, and MGI Tech (MGI), a subsidiary of global genomics leader BGI Group, ... in the United States, Europe and Asia Pacific. , Under the terms ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... services, announced it has been nominated as a finalist in the category of ... nomination comes as VGXI expedites manufacturing of a DNA vaccine against the novel ...
(Date:3/2/2020)... ... March 02, 2020 , ... Toronto-based clinical research organization (CRO) and regulatory consulting ... location just 5 minutes south of Clarksburg on a farm on Beaver Valley Road. ... of the Rainbow Orchard, and decided it would be a great new option for ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... (PRWEB) , ... March 30, 2020 , ... ... and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to bring ... pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an Emergency ...
(Date:3/27/2020)... ... March 25, 2020 , ... ... of its veterinary histopathology laboratory located centrally in the midwest for high-quality, ... to work with a highly motivated, independent, professional team that is focused ...
(Date:3/13/2020)... ... March 12, 2020 , ... Today, DuPont Nutrition ... Research Center (APC), a pioneer in the field of microbiome science, which focuses ... role in human health, based at University College Cork and Teagasc Moorepark. , ...
(Date:3/10/2020)... ... , ... Lifecycle Biotechnologies announced today that is has acquired a ... as a biopharmaceutical and biotechnology production and development campus. Lifecycle is currently updating the ... production and development hub. The company expects to relocate from Fort Worth, Texas by ...
Breaking Biology Technology:
Cached News: